Education and Training
- Univeristy of Maryland Baltimore County, BA
- George Washinton University, MD
- Walter Reed Army Medical Center, Surgery, Residency
- Walter Reed Army Medical Center, Vascular Surgery, Fellowship
- American Board of Surgery, Inc., Certifications
Dr. Charles Fox came from Denver Health and the University of Colorado where he functioned as a Trauma and Vascular Surgeon. Dr. Fox is a retired U.S. Army Lieutenant Colonel and former program director for vascular surgery training at Walter Reed Army Medical Center, Washington, DC. His medical career began as firefighter-paramedic for the Baltimore County Fire Department. After serving as an 82nd Airborne Division paratrooper, he became a special forces medic and deployed to the Middle East. Following medical school, he served as a flight surgeon for the 10th Special Forces Group in Bosnia. Following his surgical training he was deployed to Baghdad, Iraq and later as chief and trauma director for the 31st Combat Hospital in Afghanistan. Dr Fox is now a well-recognized vascular surgeon with an academic interest in hemorrhage control and vascular trauma care. He is a reviewer for the Journal of Vascular Surgery and is on the editorial boards of the Journal of Trauma and Acute Care Surgery and the Journal of Endovascular Trauma Management.
Resuscitation, Trauma, Endovascular, Vascular Surgery
DuBose JJ, Morrison J, Moore LJ, Cannon JW, Seamon M, Inaba K, Fox CJ, Moore EE, Feliciano D, Scalea T. Clamshell thoracotomy better facilitates thoracic life-saving procedures without increased complications compared to anterolateral approach to resuscitative thoracotomy: Results from the AAST AORTA registry, J. Am Coll of Surg. 2020 Sep. Online ahead of print.
Fox CJ, Moore EE. The Posterior Approach to the Mid-Popliteal Vessels is the Preferred Approach for an Isolated Knee Injury. J. Trauma Acute Care Surg. 2020 Oct;89(4): e101-e105.
Bukur M, Dubose J, Fox CJ, Scalea T, Podbielski J, Moore LJ, Temporal Changes in REBOA Utilization Practices are Associated with Increased Survival: An Analysis of the Aorta Registry. Shock. 2020 Aug 24. Online ahead of print.
Fox CJ, Morton A, Watters A, Mehler P. Abdominal Pain Associated with Anorexia Nervosa and Median Arcuate Ligament Syndrome: A Rare Condition Shadowed by a Post-Operative Conversion Disorder J. Vascular and Endovascular Surgery. Vol 54:6; 2020.
Brenner M, Moore L, Bishoy Z, Schwed A, Cralley A, Romagnoli A, Fox CJ, Scalea T, Burlew CC. Scalpel or Sheath? Outcomes comparison between Pre-Peritoneal Pelvic Packing and Angioembolization for Definitive Hemorrhage Control after REBOA. J. Endovascular Trauma Management. Vol. 4, No. 1; 2020; pp 49–55.
Plotkin S, Magee G, Fox, CJ. A standardized trauma-specific endovascular inventory. J. Trauma Acute Care Surg. 2020 Aug;89(2S Suppl 2):S83-S87.
Musawi M, Fackelmayer O, Fox CJ. Sleeve Fistulectomy: A Novel Hybrid Technique to Manage the Degenerative Arteriovenous Fistula. Ann. Vasc. Surg. 2020 Feb;63:450-453.
Magee G, Fox, CJ, Moore, EE. Resuscitative Endovascular Balloon Occlusion of the Aorta in Pelvic Ring Fractures: The Denver Health Protocol. Injury 2020 Jan.
Campion E, Cralley A, Robinson C, Sauaia A, Pieracci FM, Lawless RA, Platnick B, Robinson J, Edwards D, McVaney K Moore EE, Cohen MJ Coleman JJ, Fox CJ Burlew CC. Prehospital End Tidal Carbon Dioxide Predicts Massive Transfusion and Death Following Trauma. J. Trauma Acute Care Surg. 89(4):703-707, October 2020.
Hatchimonji J, Chipman A, McGreevy D, Hörer T, Burruss S, Han S, Spalding C, Fox CJ, Moore EE, Diaz J, Cannon J. REBOA Use in Non-trauma Emergency General Surgery: A Multi-Institutional Experience. J. Surg. Research. 2020 Jul 21;256:149-155.
Samuels J, Kaiwen S, Moore EE, Coleman J, Fox CJ, Cohen M, Sauaia A, MacTaggart J. REBOA Interest is Widespread but Usage Remains Limited. J. Trauma Acute Care Surg. 89(4): e112-e116, October 2020.
Moore L, Fox E, Meyer D, Wade C, Podbielski J, Xun X, Morrison J, Scalea T, Fox CJ, Moore EE, Morse B, Inaba K, Bulger E, Holcomb J. Prospective observational evaluation of the ER-REBOA™ catheter at six U.S. trauma centers. Ann Surg. 2020 June 23
Theodorou CM, Anderson JE, Brenner MB, Scalea TM, Inaba K, Cannon J, Seamon M, Spalding MC, Fox CJ, Moore EE, DuBose JJ, Galante JM, AAST AORTA Study Group.Practice, Practice, Practice! Effect of REBOA Volume on Outcomes: Data from the AAST AORTA Registry. J. Surg. Research. 2020 Sep;253:18-25.
Hoehn M, Fox CJ, Moore EE. Challenges in acute care surgery: Blunt celiac artery injury. J Trauma Acute Care Surg. 2020 Feb;88(2):e92-e94.
Sumislawski J, Moore HB, Moore EE, Swope M, Pieracci F, Fox CJ, Campion E, Lawless R, Platnick K, Sauaia A, Cohen MJ, Burlew CC. Not all in your head (and neck): Stroke after blunt cerebrovascular injury is associated with systemic hypercoagulability. J. Trauma Acute Care Surg. 2019 Jul 15.
Harmon, Billow, Shanmuganathan, Lauerman, Todd, Cardenas, Haugen, Albrecht, Pittman, Cohen, Kaups, Dirks, Burlew Fox, Con, Inaba, Harrison, Berg, Waller, Kallies, Kozar. Delayed Splenic Hemorrhage: Myth or Mystery? A Western Trauma Association Multicenter Study. Am J Surg. 2019 Jul.
- Endovascular Hemorrhage Control
- Resuscitation & Coagulation
- Vascular Injury Management
- Dismounted Complex Blast Injury
- Functional Outcome Following Limb Salvage
- Aortic Aneurysms
- Carotid Artery Disease
- Cerebrovascular Disease
- Peripheral Artery Disease
- Thoracic Outlet Syndrome
- Dialysis Access
- Varicose Veins
- Emergency Vascular Surgery
Dr. Fox was named a Top Doctor in the specialty of Vascular Surgery by 5280 magazine in 2017, 2018, 2019 and is a Bronze Star Medal recipient for military service in Iraq and Afghanistan.
- DOD Grant Number W81XWH2010205, " Impact of REBOA and TXA on Dysregulated Fibrinolysis and Secondary Brain Injury Following Severe Polytrauma involving Advanced Hemorrhagic Shock, Tissue Injury and Traumatic Brain Injury: Implications for Battlefield Resuscitation" Award $1,000,000.00 Effort: 5%. Role: CO-PI.
- Randomized, Multi center, Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia. COMIRB protocol 19-0103. Award $56,773 Effort 1%. Role Lead PI.
- A Phase 3 Study to Compare the Efficacy and Safety of Humacyte’s Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with End-Stage Renal Disease. COMIRB protocol 18-0015. Award $337,370.00 Effort 1.5%. Role PI.
- A phase 2 study for the evaluation of safety and efficacy of Humacyte’s human acellular vessel for use as a vascular bypass or interposition vessel in patients with limb threatening peripheral arterial trauma. COMIRB protocol 17-2351. Award $59,181.00 Effort 1.5%. Role PI.
- Emergent Truncal Hemorrhage Control Study. Observational multi-center study of the ER-REBOA catheter and other emergent interventions for non-compressible torso hemorrhage. COMIRB Protocol 17-0055. Award $334,780.00 Effort: 1.5%. Role: Lead PI.